HomeBUSINESS
BUSINESS

Amgen to Remain Active Investor in Japan as It Eyes 2020 Launch of Stand-Alone Subsidiary
(Oct.4.2018)

Amgen CEO Robert A. Bradway in Tokyo Interview
Amgen is poised to continue making active investments in Japan as it looks beyond the milestone year of 2020, when it plans to turn its Japanese joint venture with Astellas Pharma into a wholly owned subsidiary, CEO Robert A. Bradway tells Jiho ...
(LOG IN FOR FULL STORY)